Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1041 | MIRM Mirum Pharmaceuticals, Inc. - common stock | 123.18 USD | -4.00% | +3.16% | +28.92% | +75.65% | 7.51 B USD | ||
| 1048 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 112.50 USD | -1.71% | -0.84% | +28.35% | +1.99% | 7.71 B USD | ||
| 1083 | LQDA Liquidia Corporation - Common Stock | 82.55 USD | +1.63% | +4.26% | +28.16% | +265.27% | 7.34 B USD | ||
| 1114 | COGT Cogent Biosciences, Inc. - Common Stock | 38.64 USD | -3.42% | +0.42% | +21.17% | +146.59% | 6.60 B USD | ||
| 1122 | SRRK Scholar Rock Holding Corporation - Common Stock | 55.02 USD | -2.72% | +1.96% | +23.78% | +83.28% | 6.59 B USD | ||
| 1162 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 311.75 USD | -2.40% | -1.61% | +28.83% | +66.60% | 6.25 B USD | ||
| 1171 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 64.27 USD | +1.42% | +7.15% | +23.26% | +57.56% | 6.21 B USD | ||
| 1184 | CNTA Centessa Pharmaceuticals plc - American Depositary Shares | 40.50 USD | 0.00% | +1.07% | +1.94% | +65.17% | 6.27 B USD | ||
| 1238 | CRSP CRISPR Therapeutics AG - Common Shares | 60.33 USD | -0.72% | +7.73% | +14.80% | +7.92% | 5.82 B USD | ||
| 1246 | BLTE Belite Bio Inc - American Depositary Shares | 147.09 USD | -6.72% | -1.61% | +2.58% | +145.15% | 5.79 B USD | ||
| 1262 | ERAS Erasca, Inc. - Common Stock | 18.17 USD | -1.03% | +1.91% | +37.44% | +1119.46% | 5.65 B USD | ||
| 1281 | TVTX Travere Therapeutics, Inc. - Common Stock | 56.35 USD | -2.59% | -1.37% | +17.69% | +95.86% | 5.24 B USD | ||
| 1298 | CELC Celcuity Inc. - Common Stock | 109.12 USD | -5.70% | +4.36% | +24.25% | +702.94% | 5.32 B USD | ||
| 1312 | LEGN Legend Biotech Corporation - American Depositary Shares | 27.38 USD | -1.08% | -8.03% | -13.85% | -14.38% | 5.06 B USD | ||
| 1314 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 94.23 USD | -1.60% | +2.31% | +14.32% | +411.84% | 5.15 B USD | ||
| 1342 | DFTX Definium Therapeutics, Inc. - Common Shares | 45.02 USD | +1.21% | +0.76% | +94.05% | +197.95% | 4.91 B USD | ||
| 1366 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 44.89 USD | +4.08% | +15.10% | +26.63% | +194.75% | 4.83 B USD | ||
| 1383 | VKTX Viking Therapeutics, Inc. - Common Stock | 40.60 USD | -3.63% | +4.16% | +36.42% | +32.72% | 4.71 B USD | ||
| 1403 | TNGX Tango Therapeutics, Inc. - Common Stock | 30.44 USD | +1.06% | +2.77% | -5.44% | +424.83% | 4.40 B USD | ||
| 1428 | VCYT Veracyte, Inc. - Common Stock | 54.79 USD | -2.44% | -8.88% | +14.26% | +48.48% | 4.37 B USD |
Noticias Biotechnology Stocks
BofA reitera su calificación de Beam Therapeutics tras fallo arbitral
¿Por qué cae hoy la acción de Beam Therapeutics?
¿Por qué las acciones de Prime Medicine se disparan hoy?
La acción de Incyte alcanza un máximo de 52 semanas en 118,77 dólares
Las acciones de Prime Medicine suben tras ganar arbitraje contra Beam
Resultados de Nurix Therapeutics: la atención se centra en el acuerdo con Roche
Las acciones de Edgewise Therapeutics alcanzan máximos históricos a 43,96 dólares
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |